Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Group 1: Zacks Premium Overview - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, access to the Zacks 1 Rank List, Equity Research reports, and Premium stock screens [1] - The service aims to help investors become smarter and more confident in their investment decisions [1] Group 2: Zacks Style Scores - Zacks Style Scores are complementary indicators that rate stocks based on value, growth, and momentum characteristics, assisting investors in selecting stocks likely to outperform the market in the next 30 days [2] - Each stock receives a rating from A to F, with A indicating the highest potential for outperformance [3] Group 3: Value, Growth, and Momentum Scores - The Value Score focuses on identifying undervalued stocks using ratios like P/E, PEG, and Price/Sales [3] - The Growth Score emphasizes a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] - The Momentum Score identifies optimal times to invest based on price trends and earnings estimate changes [5] Group 4: VGM Score - The VGM Score combines Value, Growth, and Momentum Scores, providing a comprehensive indicator for stock selection [6] Group 5: Zacks Rank Performance - The Zacks Rank model, based on earnings estimate revisions, has shown strong performance, with 1 (Strong Buy) stocks yielding an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - There are over 800 top-rated stocks available, making it essential for investors to utilize Style Scores for effective selection [9] Group 6: Stock Analysis - Quest Diagnostics (DGX) - Quest Diagnostics Inc. provides diagnostic information services to various customers, including physicians and hospitals, and is a key provider of reference testing for about half of U.S. hospitals [12] - DGX holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B and a Momentum Style Score of B, having increased by 7.7% in the past four weeks [13] - Recent earnings estimates for fiscal 2025 have been revised higher, with the Zacks Consensus Estimate now at $9.70 per share, and an average earnings surprise of 2% [13][14]